WO2009060317A3 - Absorptive matrix methods for the diagnosis and monitoring of disease and assessment of effects of therapy - Google Patents

Absorptive matrix methods for the diagnosis and monitoring of disease and assessment of effects of therapy Download PDF

Info

Publication number
WO2009060317A3
WO2009060317A3 PCT/IB2008/003794 IB2008003794W WO2009060317A3 WO 2009060317 A3 WO2009060317 A3 WO 2009060317A3 IB 2008003794 W IB2008003794 W IB 2008003794W WO 2009060317 A3 WO2009060317 A3 WO 2009060317A3
Authority
WO
WIPO (PCT)
Prior art keywords
assessment
diagnosis
monitoring
therapy
disease
Prior art date
Application number
PCT/IB2008/003794
Other languages
French (fr)
Other versions
WO2009060317A2 (en
Inventor
Trevor T Hansel
Edward Erin
Original Assignee
Imp Innovations Ltd
Trevor T Hansel
Edward Erin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp Innovations Ltd, Trevor T Hansel, Edward Erin filed Critical Imp Innovations Ltd
Publication of WO2009060317A2 publication Critical patent/WO2009060317A2/en
Publication of WO2009060317A3 publication Critical patent/WO2009060317A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/528—Atypical element structures, e.g. gloves, rods, tampons, toilet paper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Abstract

The present disclosure provides novel, non-invasive methods and kits utilizing a porous hydroxylated polyester membrane in the assessment of symptoms and biomarkers for the diagnosis and monitoring of a subject and the assessment of novel anti-inflammatory therapies in a subject suffering from an allergic condition.
PCT/IB2008/003794 2007-11-08 2008-11-07 Absorptive matrix methods for the diagnosis and monitoring of disease and assessment of effects of therapy WO2009060317A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98640807P 2007-11-08 2007-11-08
US60/986,408 2007-11-08

Publications (2)

Publication Number Publication Date
WO2009060317A2 WO2009060317A2 (en) 2009-05-14
WO2009060317A3 true WO2009060317A3 (en) 2009-08-13

Family

ID=40626270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/003794 WO2009060317A2 (en) 2007-11-08 2008-11-07 Absorptive matrix methods for the diagnosis and monitoring of disease and assessment of effects of therapy

Country Status (1)

Country Link
WO (1) WO2009060317A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012139591A1 (en) 2011-04-13 2012-10-18 Hvidovre Hospital Monitoring liver fibrosis in a hepatitis c infected patient
CN114209716A (en) * 2021-11-26 2022-03-22 南开大学 Application of modified lysosome in preparation of drugs for treating protein misfolding or processing diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005024389A1 (en) * 2003-09-07 2005-03-17 Buettner Andrea Detection of analytes in a defined area of the body

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005024389A1 (en) * 2003-09-07 2005-03-17 Buettner Andrea Detection of analytes in a defined area of the body

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FOMOVSKA G N ET AL: "Accuwik((R))Ultra(TM) for the direct collection, storage and efficient rapid release of biological samples for clinical diagnostics", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, vol. 53, no. 6, SUPPL, 1 June 2007 (2007-06-01), pages A75, XP008106732, ISSN: 0009-9147 *
INTERNET CITATION, XP008106688, Retrieved from the Internet <URL:http://mms.technologynetworks.net/posters/0448.pdf> *
LINDEN MARGARETA ET AL: "Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, vol. 162, no. 5, 1 November 2000 (2000-11-01), pages 1705 - 1708, XP008106712, ISSN: 1073-449X, Retrieved from the Internet <URL:http://ajrccm.atsjournals.org/cgi/content/full/162/5/1705> *
SIM TOMMY C ET AL: "Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge", AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, vol. 149, no. 2, PART 1, 1 January 1994 (1994-01-01), pages 339 - 344, XP008106716, ISSN: 1044-1549 *
SIM TOMMY C ET AL: "Secretion of chemokines and other cytokines in allergen-induced nasal responses: Inhibition by topical steroid treatment", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMERICAN LUNG ASSOCIATION, NEW YORK, NY, US, vol. 152, no. 3, 1 September 1995 (1995-09-01), pages 927 - 933, XP008106715, ISSN: 1073-449X, Retrieved from the Internet <URL:http://ajrccm.atsjournals.org/cgi/content/abstract/152/3/927> *

Also Published As

Publication number Publication date
WO2009060317A2 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
WO2007137072A3 (en) Assays for diagnosing and evaluating treatment options for fabry disease
WO2007044860A3 (en) Diabetes-associated markers and methods of use thereof
WO2007061906A3 (en) Diagnostic and therapeutics for cardiovascular disorders
WO2005114190A3 (en) Methods of identifying biomarkers
WO2006024466A3 (en) Test device for the in vitro diagnosis of multi-analyte tests and the use thereof
WO2007047408A3 (en) Promac signature application
WO2009111595A9 (en) Diagnosing and monitoring depression disorders based on multiple biomarker panels
WO2006125117A3 (en) Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
WO2009100105A3 (en) Inhibitors of oncogenic isoforms and uses thereof
WO2007041245A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
WO2012076553A3 (en) Biomarkers and parameters for hypertensive disorders of pregnancy
DE602007011566D1 (en) Ankheit
WO2009018447A3 (en) Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
WO2009100131A3 (en) Process to diagnose or treat brain injury
MX2009013649A (en) Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma.
UA101167C2 (en) Pharmaceutical composition useful for the treatment of ocular disease
WO2008137835A3 (en) Auto-antibody markers of autoimmune disease
WO2009114712A3 (en) Assays for diagnosing and evaluating treatment options for pompe disease
EP2857522A3 (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
WO2010127057A3 (en) Biomarkers of therapeutic responsiveness
WO2011074802A3 (en) Kit for diagnosing prostate cancer and diagnosis method
WO2009122444A3 (en) Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers and diagnostic kit thereof
WO2005124358A3 (en) Diagnosis and treatment of siglec-6 associated diseases
WO2009060317A3 (en) Absorptive matrix methods for the diagnosis and monitoring of disease and assessment of effects of therapy
WO2010077323A3 (en) Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08848352

Country of ref document: EP

Kind code of ref document: A2